Comparison between HER2 extracellular domain in serum and HER2 overexpression in breast cancer tissue

被引：0
|
作者：
Zidan, J.
Mzalbat, R.
Shnaider, J.
Sharabi, A.
机构：
[1] Sieff Hosp, Safed, Israel
[2] Ziv Med Ctr, Safed, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e11066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11066
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Successful targeting HER2 in heavily pretreated HER2-negative metastatic breast cancer patients presenting with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells
    Kurbacher, C. M.
    Quade, A.
    Eichler, C.
    Kunstmann, G.
    Herz, S.
    Kurbacher, J. A.
    Warm, M. R.
    CANCER RESEARCH, 2016, 76
  • [32] Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab
    Wakatsuki, Takeru
    Ishizuka, Naoki
    Hironaka, Shuichi
    Minashi, Keiko
    Kadowaki, Shigenori
    Goto, Masahiro
    Shoji, Hirokazu
    Hirano, Hidekazu
    Nakayama, Izuma
    Osumi, Hiroki
    Ogura, Mariko
    Chin, Keisho
    Yamaguchi, Kensei
    Takahari, Daisuke
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) : 801 - 812
  • [33] Evaluating HER2 amplification and overexpression in breast cancer
    Bartlett, JMS
    Going, JJ
    Mallon, EA
    Watters, AD
    Reeves, JR
    Stanton, P
    Richmond, J
    Donald, B
    Ferrier, R
    Cooke, TG
    JOURNAL OF PATHOLOGY, 2001, 195 (04): : 422 - 428
  • [34] Association between HER2/neu overexpression and calcifications in breast cancer
    Christy, C. J.
    Rishi, M.
    Schwartz, J.
    Grube, B. J.
    Bossuyt, V.
    Philpotts, L.
    DiGiovanna, M. P.
    Tavassoli, F.
    Lannin, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer
    Di Modugno, Francesca
    Mottolese, Marcella
    DeMonte, Lucia
    Trono, Paola
    Balsamo, Michele
    Conidi, Andrea
    Melucci, Elisa
    Terrenato, Irene
    Belleudi, Francesca
    Torrisi, Maria Rosaria
    Alessio, Massimo
    Santoni, Angela
    Nistico, Paola
    PLOS ONE, 2010, 5 (12):
  • [36] STUDY ON SERUM HER2 EXTRACELLULAR DOMAIN EXPRESSION IN EARLY STAGE BREAST CANCER PATIENTS
    Ma, L.
    Yang, H.
    Li, J.
    Wang, F.
    Han, X.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 111 - 111
  • [37] Reassessment of HER2 status in HER2 negative or HER2 unknown breast cancer patients with recurrent metastatic disease by analyzing serum HER2 and HER2 status of circulating tumor cells.
    Fehm, T.
    Lane, N.
    Solomayer, E.
    Wallwiener, D.
    Uhr, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [38] HER2 overexpression and cancer targeting
    Wang, SC
    Hung, MC
    SEMINARS IN ONCOLOGY, 2001, 28 (05) : 115 - 124
  • [39] Comparison of HER2 expression status between conventional HER2 test and VENTANA HER2 (4B5) of metastatic breast cancer
    Tokudome, N.
    Sugino, T.
    Nishimura, S.
    Bekku, E.
    Hayashi, T.
    Tadokoro, Y.
    Takahashi, K.
    Nakashima, K.
    Uematsu, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1336 - S1337
  • [40] Comparison of the seric dosage of HER2 extracellular domain with hyperexpression-amplification of HER2 studied on metastasis biopsies of breast cancers
    Thery, J. C.
    Picquenot, J. M.
    Cornic, M.
    Lamarche, C.
    Raillot, V
    Laberge-Le-Couteulx, S.
    Veyret, C.
    Basuvau, J. P.
    Blot, E.
    BULLETIN DU CANCER, 2008, 95 (06) : 607 - 608
12345